News Conference News ESC 2019 Primary Prevention ICDs Still Render Better Survival, Even in Modern HFrEF Patients Todd Neale September 13, 2019
News Industry News Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure September 12, 2019
News Conference News ESC 2019 DAPA-HF Details: Dapagliflozin Slashes HF Outcomes, Even in Nondiabetics Shelley Wood September 01, 2019
News Conference News ESC 2019 PARAGON-HF Misses Primary Endpoint, but Hints of Benefit Seen Todd Neale September 01, 2019
News Daily News FDA Approves Baroreflex Activation Therapy Device for Advanced Heart Failure Todd Neale August 19, 2019
News Daily News Infection During CV Hospital Stays Tied to Higher Costs, Greater Death Risk Marcus A. Banks July 24, 2019
News Industry News Nanowear Announces Clinical Launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study July 22, 2019
News Industry News U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure June 26, 2019
News Features ESC Heart Failure 2019 At the ESC Heart Failure Congress, Some COAPT Converts—and Some Pushback Shelley Wood May 30, 2019
News Conference News ESC Heart Failure 2019 Early Peek Hints at Safety and Utility of V-LAP Sensor for Monitoring Left Atrial Pressure Shelley Wood May 29, 2019
News Conference News ESC Heart Failure 2019 Weaning Off Diuretics in Stable Heart Failure? ReBIC-1 Hints at Possibilities Shelley Wood May 28, 2019
News Conference News ESC Heart Failure 2019 MitraClip Benefits FMR Patients Regardless of Baseline BNP: COAPT Shelley Wood May 27, 2019
News Conference News EuroPCR 2019 MR Reduction Linked to Lower HF Hospitalizations and Deaths, Regardless of Intervention: COAPT Shelley Wood May 21, 2019
News Conference News HRS 2019 BeAT-HF: Baroreflex Activation Therapy Improves Outcomes in Subset of HF Patients Todd Neale May 15, 2019
News Daily News Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure Michael O'Riordan May 06, 2019
News Daily News Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy Michael O'Riordan May 06, 2019